首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Multicomponent closure member, in particular vehicle door, with a cast light-metal inner part
摘要
申请公布号
EP1000788(A3)
申请公布日期
2002.02.06
申请号
EP19990121934
申请日期
1999.11.08
申请人
VOLKSWAGEN AKTIENGESELLSCHAFT
发明人
BOSSE, AXEL, DIPL.-ING.
分类号
B60J5/04;E05D5/02;E05D5/06;F16B5/04;F16B19/10;(IPC1-7):B60J5/04
主分类号
B60J5/04
代理机构
代理人
主权项
地址
您可能感兴趣的专利
A method of treating abnormal cells in a non-human mammal using a echovirus which recognise alpha-1 beta-2 for infecitvity of the cells
Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation
Memory device with applications software for releasable connection to a host computer
Recombinant nucleic acid (expression) constructs and methods for regulating the expression of one or more than one coding sequence of interest
Individual isolated and purified 2S, 7S and 12S canola proteins may be used in conventional applications of protein isolates, such as, protein fortification of processed foods
APPARATUS AND METHODS FOR MANIPULATING LIGHT USING NANOSCALE COMETAL STRUCTURES
NUEVAS COMPOSICIONES TOPICAS EN FORMA DE EMULSION AC/AG QUE COMPRENDEN UN GLICOL PROPENETRANTE
Verfahren zur Verwaltung der Applikationsdaten einer Fahrzeugkomponente eines Kraftfahrzeugs
EPF receptor assays, compounds and therapeutic compositions
PROCESS FOR PRODUCING HIGH-PURITY N-VINYLCARBOXAMIDES
Sitting passenger detecting apparatus and sitting passenger detecting method
Swine population and uses thereof
Corona discharge electrode with cleaning by electric heating and method of operating the same
Diaryl ethers as opioid receptor antagonist
GroEL Chimeric Protein and vaccine
An attenuated bacterium comprising a mutation in a polynucleotide sequence that encodes an atpG polypeptide
Combinations comprising a vasculostatic compound such as vatalanib and epothilones, and pharmaceutical uses thereof
Nasal pharmaceutical composition of piribedil
Bentgrass event ASR-368 and compositions and methods for detection thereof
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders